OverviewSuggest Edit

Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging. It offers various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell culture products. The company also provides double bags, pre-filled syringes, half-type kits, glass molding vials, ampoules, cartridges, and other solutions.

TypePublic
Founded1954
HQOsaka, JP
Websitenipro.co.jp
Employee Ratings3.4

Latest Updates

Employees (est.) (Mar 2020)32,786(+12%)
Revenue (FY, 2020)¥442.5 B(+4%)
Share Price (May 2021)¥1.3 K(+2%)
Cybersecurity ratingCMore

Key People/Management at Nipro Corporation

Sano Yoshihiko

Sano Yoshihiko

President
Yoshioka Kiyotaka

Yoshioka Kiyotaka

Managing Director
Masuda Toshiaki

Masuda Toshiaki

Managing Director
Kobayashi Kyoetsu

Kobayashi Kyoetsu

Managing Director
Minoura Kimihito

Minoura Kimihito

Managing Director
Yamazaki Tsuyoshi

Yamazaki Tsuyoshi

Managing Director
Show more

Nipro Corporation Office Locations

Nipro Corporation has offices in Osaka, Bunkyo City, Kusatsu and Ohdate
Osaka, JP (HQ)
3-chōme-9-3 Honjōnishi, Kita-ku
Bunkyo City, JP
4-chōme-3-4 Hongō
Kusatsu, JP
3023 Nojicho
Kusatsu, JP
61 - 9 Sasatani, Yamadera - cho
Ohdate, JP
8-7 Hanukiyachi, Niida
Show all (5)

Nipro Corporation Financials and Metrics

Nipro Corporation Revenue

Embed Graph
View revenue for all periods
Nipro Corporation's revenue was reported to be ¥442.52 b in FY, 2020 which is a 3.8% increase from the previous period.
JPY

Revenue (Q3, 2021)

341.1b

Gross profit (Q3, 2021)

105.3b

Gross profit margin (Q3, 2021), %

30.9%

Net income (Q3, 2021)

10.9b

EBIT (Q3, 2021)

23.1b

Market capitalization (17-May-2021)

213.5b

Closing stock price (17-May-2021)

1.3k

Cash (31-Dec-2020)

106.0b

EV

657.6b
Nipro Corporation's current market capitalization is ¥213.5 b.
Annual
JPYFY, 2018FY, 2019FY, 2020

Revenue

395.4b426.4b442.5b

Revenue growth, %

8%4%

Cost of goods sold

268.3b295.8b308.3b

Gross profit

127.1b130.6b134.2b
Quarterly
JPYQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2019Q3, 2021

Revenue

103.2b208.3b321.3b109.8b222.7b336.7b108.9b222.3b341.1b

Cost of goods sold

69.6b144.4b222.1b75.7b155.9b234.6b75.2b153.8b235.8b

Gross profit

33.6b63.9b99.2b34.0b66.7b102.1b33.7b68.4b105.3b

Gross profit Margin, %

33%31%31%31%30%30%31%31%31%
Annual
JPYFY, 2018FY, 2019FY, 2020

Cash

141.9b129.4b95.9b

Accounts Receivable

140.5b149.0b152.5b

Inventories

129.2b137.9b153.3b

Current Assets

436.0b443.0b433.0b
Annual
JPYFY, 2018FY, 2019FY, 2020

Net Income

12.3b11.9b(11.6b)

Depreciation and Amortization

38.2b39.5b47.5b

Inventories

(4.9b)(11.4b)(15.2b)

Accounts Payable

(3.8b)11.8b205.0m
Half Year
JPYH1, 2019H1, 2020H1, 2021

Net Income

7.7b6.2b5.8b

Depreciation and Amortization

18.2b19.8b19.8b

Inventories

(3.3b)(6.8b)(10.2b)

Accounts Payable

5.8b(173.0m)2.4b
JPYFY, 2018

Revenue/Employee

14.0m

Debt/Equity

2.8 x

Debt/Assets

0.6 x

Financial Leverage

4.5 x
Show all financial metrics

Nipro Corporation Operating Metrics

Y, 2018Y, 2019Y, 2020

Ampoules/Vials Produced

700 m700 m

Dual Chamber Bags Produced

33 m33 m33 m

Pre-filled Syringes Produced

160 m160 m160 m

Tablets Produced

14 b14.8 b14.8 b
Show all operating metrics

Nipro Corporation Acquisitions / Subsidiaries

Company NameDateDeal Size
InfraredxOctober 01, 2015
Home DiagnosticsFebruary 03, 2010
NIPRO MEDICAL (HEFEI) CO., LTD
Nipro PharmaPackaging (Shanghai) Co., Ltd.
Nipro (Shanghai) Co., LTD.
Nipro Trading (Shanghai) Co., Ltd.

Nipro Corporation Revenue Breakdown

Embed Graph

Nipro Corporation revenue breakdown by business segment: 8.2% from PharmaPackaging, 15.9% from Pharmaceutical-Related, 75.9% from Medical-Related and 0.0% from Other

Nipro Corporation revenue breakdown by geographic segment: 60.5% from Japan, 14.5% from Americas, 11.5% from Europe and 13.5% from Asia

Nipro Corporation Cybersecurity Score

Cybersecurity ratingPremium dataset

C

75/100

SecurityScorecard logo

Nipro Corporation Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Nipro Corporation Online and Social Media Presence

Embed Graph

Nipro Corporation News and Updates

Nipro Medical Corporation announces the creation of Vascular Division in the U.S.

Nipro Medical Corporation (NMC), a leading Renal, Medical, Surgical, and Interventional Radiology products manufacturer, announces the creation of a Vascular Division in the U.S. The division will include several cutting-edge technologies, innovative vascular and cardiovascular products to provide c…

ニプロシリンジ(ローデッドタイプ)の増産ならびに

ニプロ株式会社(本社:大阪市北区、代表取締役社長:佐野 嘉彦、以下「当社」)は、このたびニプロシリンジ (ローデッドタイプ)の製造ライン強化による増産体制が整い、2021 年度に約 5,000 万本の生産が可能となりまし たことを、お知らせいたします。

中国における海外拠点開設のお知らせ

このたび、中華人民共和国の吉林省の省都・長春市(チョウシュン)に、当社連結子会社 尼普洛貿易(上海) 有限公司の営業事務所を開設しましたので、お知らせいたします。

新たな止血材「ノブリード®」販売開始のお知らせ

ニプロ株式会社(本社:大阪市北区、代表取締役社長:佐野 嘉彦)は、2021 年 3 月 23 日より カチオン化セルロースを主成分とした止血材「ノブリード®」(以下、「本製品」)の販売を開始しまし たので、お知らせいたします。

純国産・医療用高性能マスクの共同開発について

国立循環器病研究センター(大阪府吹田市、理事長:小川久雄、略称:国循)の西村邦宏 予防医学・疫学情報部長及び白石公教育推進部長と、株式会社クロスエフェクト(京都府京 都市、代表取締役:竹田正俊、以下クロスエフェクト)と、ニプロ株式会社(大阪府大阪市、 代表取締役社長:佐野嘉彦、以下ニプロ)と、ダイキン工業株式会社(大阪府大阪市、代表 取締役社長兼 CEO:十河政則、以下ダイキン工業)は、令和 2 年 9 月 2 日付プレスリリース でお知らせした通り四者による開発チームを結成し、純国産・医療用高性能マスクの共同開 発を行っております。

過疎地域における 5G を活用した遠隔診療・リハビリ指導の実証実験を実施

株式会社NTTデータ経営研究所(本社:東京都千代田区、代表取締役社長:柳 圭一郎)、株式会社NTTド コモ(本社:東京都千代田区、代表取締役社長:井伊 基之)、新城市民病院(所在地:愛知県新城市 病院長: 綿引 洋一)、東海国立大学機構 名古屋大学(所在地:愛知県名古屋市 総長:松尾 清一)、新城市(愛知県 新城市 市長:穂積 亮次)、国立研究開発法人理化学研究所(理事長:松本 紘)、ニプロ株式会社(本社:大 阪市北区、代表取締役社長:佐野 嘉彦)、株式会社ソシオネクスト(本社:神奈川県横浜市、代表取締役社長: 岡本 𠮷史)は、総務省「地域課題解決型ローカル 5G 等の実現に向けた…
Show more

Nipro Corporation Frequently Asked Questions

  • When was Nipro Corporation founded?

    Nipro Corporation was founded in 1954.

  • Who are Nipro Corporation key executives?

    Nipro Corporation's key executives are Sano Yoshihiko, Yoshioka Kiyotaka and Masuda Toshiaki.

  • How many employees does Nipro Corporation have?

    Nipro Corporation has 32,786 employees.

  • What is Nipro Corporation revenue?

    Latest Nipro Corporation annual revenue is ¥442.5 b.

  • What is Nipro Corporation revenue per employee?

    Latest Nipro Corporation revenue per employee is ¥13.5 m.

  • Who are Nipro Corporation competitors?

    Competitors of Nipro Corporation include West Pharmaceutical Services, Eisai and Kuraray.

  • Where is Nipro Corporation headquarters?

    Nipro Corporation headquarters is located at 3-chōme-9-3 Honjōnishi, Kita-ku, Osaka.

  • Where are Nipro Corporation offices?

    Nipro Corporation has offices in Osaka, Bunkyo City, Kusatsu and Ohdate.

  • How many offices does Nipro Corporation have?

    Nipro Corporation has 5 offices.